Metropolis Healthcare Ltd.

NSE: METROPOLIS | BSE: 542650 | ISIN: INE112L01020 | Industry: Healthcare Services
| Momentum Trap
1931.0000 -3.10 (-0.16%)
NSE Nov 28, 2025 15:31 PM
Volume: 9,240
 

1931.00
-0.16%
ICICI Securities Limited
Metropolis’ Q1FY24 revenue growth (-1%) and EBITDA margin (-180bps) were impacted by discontinuation of a PPP contract (Q1FY23 sales of INR 200mn) while the core business grew 12% YoY. Metropolis remains committed to expand its network by: 1) deepening its presence in existing cities and venturing into newer ones, 2) connecting directly with consumers to increase B2C share, 3) M&As to improvise scale and restore margins to pre-covid levels.
Number of FII/FPI investors increased from 171 to 177 in Sep 2025 qtr.
More from Metropolis Healthcare Ltd.
Recommended